First IBM Watson’s ground-breaking work in discovering new candidates for R&D and now Teva Pharmaceuticals AI solution for patient support. Is this the beginning of a wave of AI disruption throughout pharma?

Developed in collaboration with Next IT Healthcare, Claire uses techniques from AI and machine learning to radically re-think how patient support is delivered.

The solution has been launched to help Multiple sclerosis (MS) patients understand treatment options, identify health service points and address other common questions around disease education.

Claire communicates with patients using voice, text and graphics. By working in support with a research analyst, the Claire learns from ongoing patient interactions to improve the quality of future user experience and dialogue.

Patient support has been a necessary but expensive driver of cost for product launches, and by substituting technology for labor, Teva aims to free up resources that could either lower the costs of delivering care, or allow support to be expanded elsewhere. Either outcome will be a step forward for the patient-centricity in the delivery of care.

The winning projects were selected from hundreds of initiatives from across the USA, and announced yesterday at the 2nd annual eyeforpharma Philadelphia Awards ceremony, and determined by an international judging panel of senior industry experts, and patient advocates.

The ‘Most Valuable HCP or Healthcare Initiative’, previously won by the JointMan® Clincial Population Health Tool by Discus Analytics, is designed to celebrate innovation that improves healthcare delivery both in the long and short term.

This award category, and others, reflects eyeforpharma’s mission to evangelize the need for pharma to change its focus from selling products, to seeing the powerful opportunity that pharma has to impact and improve the lives of patients.